Telopinsit Tablet 80/5/25 mg (Telmisartan, Amlodipine Besilate, Chlorthalidone)

Adult dose

This medication is taken once daily, 1 tablet, with or without food. It is recommended to take it at the same time each day (e.g., in the morning). For patients whose blood pressure is not controlled with telmisartan/amlodipine combination therapy, 40/5/12.5 mg may be administered, adjusting the dose at intervals of more than 2 weeks considering the patient's blood pressure response. The maximum recommended dose of this medication is 80/5/25 mg.

This medication should not be taken during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. If pregnancy is confirmed, immediately discontinue use and consult a physician. Patients with impaired liver function or ongoing liver disease should be cautious, as this medication may induce hepatic coma. It is advisable not to use this medication in patients with severely impaired kidney function, as it may worsen kidney function. Patients with hypersensitivity to this medication or its ingredients, or those with certain cardiac diseases, obstructive biliary disease, etc., should not take it. Breastfeeding women should also avoid this medication and must discontinue breastfeeding if taking it. Elderly patients or those with specific cardiovascular diseases or electrolyte imbalances require special caution during administration. This medication has blood pressure-lowering effects, so hypotensive symptoms may arise, and if severe symptoms occur, inform a physician immediately. Regular blood tests should be conducted to monitor potassium levels, as this medication may raise serum potassium levels. Drug interactions may occur when taken with other medications, so inform your physician or pharmacist about all medications being taken. Caution is needed when driving or operating machinery, as dizziness or drowsiness may occur. Possible adverse reactions during use include dizziness, headache, rash, hypotension, etc., and if severe symptoms manifest, consult an expert. In cases of overdose, seek immediate medical attention for appropriate treatment; emergency treatment may be needed for hypotension or electrolyte imbalances. The safety of this medication has not been established in children, so it is not recommended for those under 18 years of age. Store in a cool, dry place out of reach of children, and protect from direct sunlight.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, pallor, severe rash with high fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities with cough and fever, yellowing of skin or eyes (jaundice), extreme drowsiness, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination

Mild side effects

• Dizziness
• headache
• abdominal pain
• nausea
• constipation
• lethargy
• hypokalemia
• hyponatremia
• gingivitis
• rash

This medication is sensitive to light and should be stored in a container that protects it from light. Additionally, it is best stored at room temperature between 1 to 30 degrees Celsius. This helps to maintain the drug’s efficacy and stability.

Appearance

White oval bi-layer tablet

Package unit

30 tablets/box [10 tablets/PTP×3]